Indication: This vaccine is used to prevent infectious diseases caused by Haemophilus influenzae type b in children between 2 months and 5 years old, such as meningitis, pneumonia, sepsis, epiglottitis, etc. This vaccine cannot prevent infections caused by other bacteria, nor can it prevent meningitis and pneumonia caused by other reasons.

Indication: This vaccine is used to prevent infectious diseases caused by Haemophilus influenzae type b in children between 2 months and 5 years old, such as meningitis, pneumonia, sepsis, epiglottitis, etc. This vaccine cannot prevent infections caused by other bacteria, nor can it prevent meningitis and pneumonia caused by other reasons.

Indication: 1. Primary hypercholesterolemia and mixed hyperlipidemia, to reduce elevated TC, LDL-C, ApoB and TG levels. 2. Patients with hypercholesterolemia and risk of atherosclerosis.

Indication: Adults with hypercholesterolemia and/or hypertriglyceridemia who are unsatisfactory with dietary therapy.

Indication: The following infectious diseases caused by Gram-positive bacteria: 1. Tonsillitis, suppurative otitis media, sinusitis, etc. 2. Acute bronchitis, acute exacerbation of chronic bronchitis, pneumonia, lung abscess and bronchiectasis combined infection, etc. 3. Skin and soft tissue infections: furuncle, sore, abscess, cellulitis, trauma, burns and surgical infection, etc. 4. Urinary system infection: acute urethritis, acute pyelonephritis, prostatitis, etc. 5. Others: myelitis, sepsis, peritonitis and oral infection, etc. Various infectious diseases caused by anaerobic bacteria: 1. Empyema, muscle abscess, anaerobic pneumonia. 2. Skin and soft tissue infection, sepsis. 3. Intraperitoneal infection: peritonitis, intraperitoneal abscess. 4. Female pelvic and genital infections: endometritis, non-gonococcal fallopian tube and ovarian abscess.

Indication: Suitable for primary hyperlipidemia.

Indication: This drug can treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides. Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product if the effects of diet therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies or alone (when no other treatments are available) to lower total cholesterol and low-density lipoprotein cholesterol. It is mainly suitable for the treatment of hypercholesterolemia and mixed hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.